When a physician orders a diagnostic lab test, the assumption embedded in that order is that the patient can complete it.
For patients in major metropolitan areas, that assumption is usually correct. Draw sites are accessible. Scheduling is manageable. The specimen gets collected, processed, and reported within a reasonable window.
For patients in rural communities, smaller cities, and underserved areas across the United States, that assumption frequently fails. Not because the test isn't available. Not because the physician didn't prioritize it. Because the infrastructure needed to collect the specimen — a qualified, available draw site within a practical distance — doesn't exist.
The result is a gap between what diagnostic medicine can do and what it actually delivers to patients in the communities that need it most.
The Centers for Disease Control and Prevention's ongoing research on rural health in the United States consistently documents that rural Americans face significantly greater barriers to healthcare access than their urban counterparts across nearly every measure — primary care availability, specialist access, emergency services, and diagnostic testing.
Rural communities are more likely to have higher rates of chronic disease, including conditions that require regular diagnostic monitoring: diabetes, heart disease, chronic kidney disease, and cancer. They're also more likely to have limited access to the healthcare infrastructure needed to manage those conditions effectively.
The patients who most need regular diagnostic monitoring are often the same patients who have the least access to the collection infrastructure that makes monitoring possible.
The collection gap in specialty diagnostics reflects this broader pattern. National draw site networks are concentrated in metropolitan areas. Specialty collection infrastructure — the credentialed, trained collectors equipped to handle kit-based specialty tests, molecular panels, and genetic specimens — is even more concentrated. In many rural counties, qualified specialty collection simply doesn't exist.
For a patient in a rural community with a physician who has ordered a specialty panel, the practical path to completing that draw may require traveling 40, 60, or more than 100 miles to reach a draw site equipped to handle it. For patients managing serious conditions — fatigue, limited mobility, transportation challenges, inflexible work schedules — that distance is often prohibitive.
An uncompleted lab order doesn't generate an error message. It doesn't trigger an automatic follow-up. It disappears.
From the lab's perspective: an order that was placed and never resulted in a specimen. From the physician's perspective: a patient who was referred and didn't complete the draw. From the healthcare system's perspective: a data point that gets filed under "patient non-compliance" — a label that attributes the failure to the patient rather than to the infrastructure that failed them.
But for the patient, the consequences are real and specific.
A specialty test that goes uncompleted delays the diagnostic information it was designed to provide. For tests that detect conditions early — genetic panels, cancer biomarkers, rare disease screens — the delay isn't administrative. It's clinical. Early detection matters. The interval between when a test is ordered and when a result is available is an interval in which a condition can progress.
Many specialty tests aren't a one-time diagnostics. They're part of an ongoing monitoring protocol — a series of draws over time that track a condition, assess treatment response, or provide early warning of complications. When access barriers make regular collection impractical, monitoring continuity breaks down. The data that a physician relies on to make treatment decisions becomes incomplete.
For patients who repeatedly encounter access barriers to completing lab orders, the cumulative effect is a pattern of under-monitored care. Conditions that should be caught early get caught late. Treatment adjustments that should happen in response to lab data get delayed because the data doesn't arrive. The patient's health outcomes reflect the gap between what their care plan required and what the access infrastructure made possible.
The collection access gap is an infrastructure problem. Infrastructure problems are solvable.
My One Medical Source (MOMS)® was built specifically to close the gap between where specialty diagnostic testing exists and where patients who need it actually live. By connecting specialty labs to a national network of MAPs: Medical Access Points/Providers™ — credentialed, trained collection professionals across all 50 states, including DC and Puerto Rico — MOMS makes it possible for patients to complete the tests their physicians order, in communities that general-purpose collection networks haven't served.
The MOMS MAP network reaches into rural counties, smaller MSAs, and underserved communities that sit outside the geographic footprint of most national draw networks. When a specialty lab connects to MOMS, their patients in those communities gain access to qualified collection resources that may not have previously existed in their area.
That's not a modest operational improvement. For a patient in a rural county whose physician has offered a specialty panel they couldn't previously complete, it's the difference between receiving a diagnosis and waiting.
If you've been unable to complete a lab test because there was no qualified collection site close enough — or if you're currently managing a condition that requires regular diagnostic monitoring and struggling to access collection services — there are things worth knowing:
Ask your physician whether your lab works with a specialty collection network. Labs that partner with MOMS have MAP coverage that may include collection resources in your area that you're not currently aware of.
Diagnostic medicine has made extraordinary advances in what it can detect and what those detections can do for patients. The infrastructure that delivers those advances to patients in rural and underserved communities is catching up.
MOMS is part of how it gets there.